Pinnacle Wealth Planning Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.1K Buy
69
+2
+3% +$698 ﹤0.01% 1651
2026
Q2
$19.7K Sell
67
-16
-19% -$4.54K ﹤0.01% 1791
2026
Q1
$23.1K Sell
83
-7
-8% -$2.02K ﹤0.01% 1621
2025
Q4
$27.3K Buy
+90
New +$28.1K ﹤0.01% 1566
2021
Q1
– Sell
-175
Closed -$102K – 541
2020
Q4
$102K Buy
+175
New +$100K 0.02% 459

Other funds holding BIO

Pinnacle Wealth Planning Services's BIO Position: Q3 2026 in Review

Pinnacle Wealth Planning Services increased its Bio-Rad Laboratories Class A (BIO) stake by 3% in Q3 2026, buying an estimated $698 and bringing the position to 69 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

Pinnacle Wealth Planning Services first reported a position in BIO in Q4 2020 and has held it in 5 quarters since. The position peaked at $102K in Q4 2020. 419 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Pinnacle Wealth Planning Services held 69 shares of Bio-Rad Laboratories Class A worth $26.1K as of Q3 2026.
  • Pinnacle Wealth Planning Services bought 2 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $698.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #1651 holding.
  • Pinnacle Wealth Planning Services first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and has held it in 5 quarters since.
  • Pinnacle Wealth Planning Services's Bio-Rad Laboratories Class A position peaked at $102K in Q4 2020.
  • 419 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.